Abstract
Background and aims: This pilot study evaluated the performance of a recently developed computer-aided detection (CADe) system for Barrett's neoplasia during live endoscopic procedures. Methods: Fifteen patients with a visible lesion and 15 without were included in this study. A CAD-assisted workflow was used that included a slow pullback video recording of the entire Barrett's segment with live CADe assistance, followed by CADe-assisted level-based video recordings every 2 cm of the Barrett's segment. Outcomes were per-patient and per-level diagnostic accuracy of the CAD-assisted workflow, in which the primary outcome was per-patient in vivo CADe sensitivity. Results: In the per-patient analyses, the CADe system detected all visible lesions (sensitivity 100%). Per-patient CADe specificity was 53%. Per-level sensitivity and specificity of the CADe assisted workflow were 100% and 73%, respectively. Conclusions: In this pilot study, detection by the CADe system of all potentially neoplastic lesions in Barrett's esophagus was comparable to that of an expert endoscopist. Continued refinement of the system may improve specificity. External validation in larger multicenter studies is planned. (Clinical trial registration number: NCT05628441.)
| Original language | English |
|---|---|
| Pages (from-to) | 527-531.e3 |
| Number of pages | 8 |
| Journal | Gastrointestinal Endoscopy |
| Volume | 100 |
| Issue number | 3 |
| Early online date | 9 Apr 2024 |
| DOIs | |
| Publication status | Published - Sept 2024 |
Bibliographical note
The authors thank the members and collaborators of the BONS-AI consortium, as listed here in alphabetical order: Alaa Alkhalaf, Isala Hospital, Zwolle, the Netherlands; Lorenza Alvarez Herrero, St. Antonius Hospital, Utrecht, the Netherlands; Francisco Baldaque-Silva, Karolinska University Hospital, Stockholm, Sweden; Maximilien Barret, Cochin Hospital, Paris, France; Jacques J. Bergman, Amsterdam UMC, Amsterdam, the Netherlands; Torsten Beyna, Evangelisches Krankenhaus D\u00FCsseldorf, D\u00FCsseldorf, Germany; Tim G. Boers, TU Eindhoven, Eindhoven, the Netherlands; Peter Elbe, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden; Kiki N. Fockens, Amsterdam UMC, Amsterdam, the Netherlands; Albert J. de Groof, Amsterdam UMC, Amsterdam, the Netherlands; Martin H. Houben, HagaZiekenhuis, The Hague, the Netherlands; Martijn Jong, Amsterdam UMC, Amsterdam, the Netherlands; Jelmer B. Jukema, Amsterdam UMC, Amsterdam, the Netherlands; Koen C. Kusters, TU Eindhoven, Eindhoven, the Netherlands; Rosalie C. Mallant-Hent, Flevoziekenhuis, Almere, the Netherlands; Guiomar Moral Villarejo, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Wouter Nagengast, UMC Groningen, Groningen, the Netherlands; Jacobo Ortiz Fern\u00E1ndez-Sordo, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Oliver Pech, St. John of God Hospital, Regensburg, Germany; Roos E. Pouw, Amsterdam UMC, Amsterdam, the Netherlands; Joost A. van der Putten, TU Eindhoven, Eindhoven, the Netherlands; Krish Ragunath, Royal Perth Hospital, Perth, Australia; Pieter Scholten, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands; Stefan Seewald, Klinik Hirslanden, Zurich, Switzerland; Fons van der Sommen, TU Eindhoven, Eindhoven, the Netherlands; Jessie Westerhof, UMC Groningen, Groningen, the Netherlands; Bas L. Weusten, UMC Utrecht & St. Antonius Hospital, Utrecht, the Netherlands; and Peter H. de With, TU Eindhoven, Eindhoven, the Netherlands. Research support provided by Olympus Tokyo.Keywords
- Adenocarcinoma/pathology
- Aged
- Aged, 80 and over
- Barrett Esophagus/pathology
- Diagnosis, Computer-Assisted
- Esophageal Neoplasms/pathology
- Esophagoscopy/methods
- Female
- Humans
- Male
- Middle Aged
- Pilot Projects
- Sensitivity and Specificity
- Video Recording